Galapagos NV (NASDAQ:GLPG) Accelerates Strategic Pivot, Immediately Refocuses Capital Toward Non-Cell Therapy Deals
![]() |
Galapagos moves decisively from cell therapy toward targeted business development while technical indicators show short-term bullish momentum offset by signs of over-extension. Fundamentals reflect a strong cash position alongside continued operating losses that frame near-term capital deployment. |









